This webinar highlighted the association between oxygen saturations and COVID-19 which underpins the need for the COVID Oximetry @home pathway. Hosted by the Royal College of General Practitioners and the Academic Health Science Network (AHSN Network), it shared a collaborative approach to monitor and manage patients at risk of sudden deterioration.
The session was chaired by Professor Maureen Baker, former Chair of the Royal College of General Practitioners, and featured the following speakers:
- Gail Allsopp, Clinical lead for Clinical Policy, RCGP, and Medical Director for East Midlands AHSN
- Matt Inada-Kim, National Clinical Lead for Deterioration, NHS England and NHS Improvement
- Karen Kirkham, Clinical Lead for Dorset Integrated Care System
- Alison Tavaré, Clinical Lead for West of England AHSN and Regional Clinical Lead COVID Oximetry @home
You can watch a recording of the webinar and download the presentation.
The webinar covered:
- Silent hypoxia, COVID-19 and emerging evidence
- The COVID Oximetry @home model and why it’s important
- NIHR evaluation of COVID Oximetry @home and opportunities to be involved
- Vulnerable patient groups including care home residents and people with a learning disability.
More RCGP/AHSN webinars
This is the fourth in a series jointly organised by the Royal College of General Practitioners and the AHSN Network. Further information can be found in the other webinars.
- COVID-19: Patient assessment and the role of physiology and oximetry
- Primary care in care homes during COVID-19
- COVID-19 and children.
Follow this link for more information on patient safety during COVID-19.
The NHS Innovation Accelerator (NIA) has revealed its 2025 cohort of Fellows. As the NIA celebrates a decade of helping to drive innovation in the NHS, this year’s cohort aligns with the Government’s three priorities: supporting the transition from analogue to digital, sickness to prevention and hospital to home. The 28 new Fellows will benefit [...]
A new guide aimed at helping primary care organisations and integrated care boards understand and address problematic polypharmacy has been launched by the Health Innovation Network as part of its national Polypharmacy Programme. Developed in response to a clear need identified by primary care and prescribing colleagues, this essential resource provides practical, evidence-based strategies to [...]
Across England, innovation is improving cancer services and patient outcomes. Last week the government launched an open call for evidence to inform the National Cancer Plan. Innovation has a critical role to play in supporting the delivery of any National Cancer Plan, and delivering on the government’s three shifts. In order to realise the significant [...]
